738 related articles for article (PubMed ID: 22613842)
1. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.
Bjaanæs MM; Fleischer T; Halvorsen AR; Daunay A; Busato F; Solberg S; Jørgensen L; Kure E; Edvardsen H; Børresen-Dale AL; Brustugun OT; Tost J; Kristensen V; Helland Å
Mol Oncol; 2016 Feb; 10(2):330-43. PubMed ID: 26601720
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.
Mansfield AS; Wang L; Cunningham JM; Jen J; Kolbert CP; Sun Z; Yang P
Cancer Genet; 2015 May; 208(5):253-60. PubMed ID: 25650174
[TBL] [Abstract][Full Text] [Related]
5. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
[TBL] [Abstract][Full Text] [Related]
7. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
[TBL] [Abstract][Full Text] [Related]
10. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
11. MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.
Castro IC; Breiling A; Luetkenhaus K; Ceteci F; Hausmann S; Kress S; Lyko F; Rudel T; Rapp UR
Mol Cancer Res; 2013 Feb; 11(2):161-72. PubMed ID: 23239811
[TBL] [Abstract][Full Text] [Related]
12. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.
Sudhir PR; Chen CH; Pavana Kumari M; Wang MJ; Tsou CC; Sung TY; Chen JY; Chen CH
Mol Cell Proteomics; 2012 Oct; 11(10):901-15. PubMed ID: 22761399
[TBL] [Abstract][Full Text] [Related]
13. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
14. RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.
Omar MF; Ito K; Nga ME; Soo R; Peh BK; Ismail TM; Thakkar B; Soong R; Ito Y; Salto-Tellez M
Pathol Oncol Res; 2012 Oct; 18(4):783-92. PubMed ID: 22729835
[TBL] [Abstract][Full Text] [Related]
15. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Fennell L; Dumenil T; Wockner L; Hartel G; Nones K; Bond C; Borowsky J; Liu C; McKeone D; Bowdler L; Montgomery G; Klein K; Hoffmann I; Patch AM; Kazakoff S; Pearson J; Waddell N; Wirapati P; Lochhead P; Imamura Y; Ogino S; Shao R; Tejpar S; Leggett B; Whitehall V
Cell Mol Gastroenterol Hepatol; 2019; 8(2):269-290. PubMed ID: 30954552
[TBL] [Abstract][Full Text] [Related]
16. Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS wild-type lung adenocarcinoma reveals gene signatures associated with patient outcome.
Planck M; Isaksson S; Veerla S; Staaf J
Clin Cancer Res; 2013 Sep; 19(18):5116-26. PubMed ID: 23938291
[TBL] [Abstract][Full Text] [Related]
17. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
[TBL] [Abstract][Full Text] [Related]
18. p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation.
Lee MO; Lee HJ; Kim MA; Kim EK; Lee JH; Heo JH; Lee SH; Cho SH; Fornace AJ; Jeong HC; Cha HJ
J Thorac Oncol; 2011 Mar; 6(3):423-31. PubMed ID: 21164364
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway.
Li J; Huang KL; Zhang T; Li H; Zhao J; Wang H
Neoplasma; 2016; 63(2):208-14. PubMed ID: 26774141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]